Study to Assess Absolute Bioavailability (ABA) of TAK-906 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]-TAK-906 in Healthy Male Participants
Clinical trial NCT04454918 · COMPLETED
Trial details
- NCT number
- NCT04454918
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-30
- Primary completion
- 2020-09-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.